Projects

A phase III, multicentre, randomized, double blind, placebo controlled, parallel group study of two dosing regimens of Fostamatinib disodium in Rheumatoid arthritis patients with an inadequate response to DMARDS

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2010 - 2010

Project Lead

Dr Joe Joseph Cherian

Authors

Dr. Joe Joseph Cherian

Project Status

completed

Project Type

Phase III